Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9P7K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,246
Award facts
- Contract value 100% obligated
- $30,246.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,246.46 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026.
Vraylar is a neurological medication used in the treatment of psychiatric conditions, and this procurement supports DLA's mission to supply pharmaceutical products to military healthcare systems and federal medical supply chains. AmerisourceBergen Drug Corp's comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support defense health operations worldwide. The company's federal contract portfolio demonstrates its established capability to meet competitive procurement requirements and deliver critical medical commodities across multiple therapeutic domains to military healthcare programs and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9P7K?
SPE2DR26F9P7K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F9P7K worth?
The government has obligated $30,246 on SPE2DR26F9P7K.
Is contract SPE2DR26F9P7K an order under another contract?
Yes. SPE2DR26F9P7K is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P7K competed?
The extent of competition for SPE2DR26F9P7K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award